Flat Luneburg lens via transformation optics for directive antenna applications

C Mateo-Segura, A Dyke, H Dyke… - IEEE Transactions on …, 2014 - ieeexplore.ieee.org
The great flexibility offered by transformation optics for controlling electromagnetic radiation
by virtually re-shaping the electromagnetic space has inspired a myriad of dream-tailored …

Update on the therapeutic potential of PDE4 inhibitors

JG Montana, HJ Dyke - Expert opinion on investigational drugs, 2002 - Taylor & Francis
Phosphodiesterase (PDE) enzymes are responsible for the inactiviation of cyclic adenosine
monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Phosphodiesterase …

[HTML][HTML] Transformation optics for antennas: why limit the bandwidth with metamaterials?

…, W Tang, RC Mitchell-Thomas, A Dyke, H Dyke… - Scientific reports, 2013 - nature.com
In the last decade, a technique termed transformation optics has been developed for the
design of novel electromagnetic devices. This method defines the exact modification of …

Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors

…, RJ Bull, C Chang, G Deshmukh, HJ Dyke… - Journal of Medicinal …, 2012 - ACS Publications
A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as
rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred …

A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor

DE Clark, C Higgs, SP Wren, HJ Dyke… - Journal of medicinal …, 2004 - ACS Publications
Melanin-concentrating hormone (MCH) has been known to be an appetite-stimulating peptide
for a number of years. However, it is only recently that MCH has been discovered to be the …

1H-Pyrazolo [3, 4-g] hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity

…, S Ward, PH Crackett, C Hurley, HJ Dyke… - Bioorganic & medicinal …, 2008 - Elsevier
Addition of the 4-fluorophenylpyrazole group to the previously described 2-azadecalin
glucocorticoid receptor (GR) antagonist 1 resulted in significantly enhanced functional activity. …

Novel 7-methoxy-6-oxazol-5-yl-2, 3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors

HL Birch, GM Buckley, N Davies, HJ Dyke… - Bioorganic & medicinal …, 2005 - Elsevier
… Buckley , Natasha Davies , Hazel J. Dyke † , Elizabeth J. Frost , Philip J. Gilbert , Duncan
R. … Davies, HJ Dyke, PJ Gilbert, DR Hannah, AF Haughan, CA Hunt, WR Pitt, RH Profit …

Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–activity relationships

GM Buckley, N Davies, HJ Dyke, PJ Gilbert… - Bioorganic & medicinal …, 2005 - Elsevier
The development of a series of novel quinazolinethiones and quinazolinediones as inhibitors
of inosine monophosphate dehydrogenase (IMPDH) is described. The synthesis, in vitro …

Rearrangement of cyclobutenones to 2, 5-and 2, 6-dialkylated 1, 4-benzoquinones. Synthesis of O-methylperezone and O-methylisoperezone

ST Perri, HJ Dyke, HW Moore - The Journal of Organic Chemistry, 1989 - ACS Publications
2, 5-Dialkylated benzoquinoneshave been prepared from 4-alkenyl-4-hydroxycyclobutenones
by thermolysis followed by oxidation, while 2, 6-dialkylated benzoquinones are available …

Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors

MJ Barnes, N Cooper, RJ Davenport, HJ Dyke… - Bioorganic & medicinal …, 2001 - Elsevier
… Author links open overlay panel Matthew J Barnes , Nicola Cooper , Richard J Davenport
, Hazel J Dyke , Fiona P Galleway , Frances CA Galvin , Lewis Gowers , Alan F Haughan …